W
WSI Co Ltd
KOSDAQ:299170
WSI Co Ltd
KOSDAQ:299170
Price:
3 210
KRW
Market Cap:
₩133.2B
WSI Co Ltd
Intangible Assets
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
WSI Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Intangible Assets
₩4.3B
|
CAGR 3-Years
75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Intangible Assets
₩4.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
25%
|
CAGR 10-Years
6%
|
|
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Intangible Assets
₩12.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
72%
|
CAGR 10-Years
5%
|
|
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Intangible Assets
₩58.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
31%
|
|
|
B
|
BlueMTec Co Ltd
KOSDAQ:439580
|
Intangible Assets
₩803.4m
|
CAGR 3-Years
219%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
WSI Co Ltd
Glance View
WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.
Intrinsic Value
1 696.71
KRW
Overvaluation 47%
W
See Also
What is WSI Co Ltd's Intangible Assets?
Intangible Assets
4.3B
KRW
4.3B
KRW
Based on the financial report for Dec 31, 2024, WSI Co Ltd's Intangible Assets amounts to 4.3B KRW.
What is WSI Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
75%
75%
Over the last year, the Intangible Assets growth was 355%. The average annual Intangible Assets growth rates for WSI Co Ltd have been 75% over the past three years .
